Human Genome Epidemiology Literature Finder
|
Records 1 - 26 (of 26 Records) |
| Query Trace: Carcinoma and UGT1A1[original query] |
|---|
| Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer. British journal of clinical pharmacology 2005 Apr 59 (4): 415-24. Zhou Qingyu, Sparreboom Alex, Tan Eng-Huat, Cheung Yin-Bun, Lee Ann, Poon Donald, Lee Edmund J D, Chowbay Balr |
| Polymorphisms of uridine-diphosphoglucuronosyltransferase 1A7 gene in Taiwan Chinese. World journal of gastroenterology : WJG 2005 Feb 11 (6): 797-802. Huang May-Jen, Yang Sien-Sing, Lin Min-Shung, Huang Ching-Sh |
| Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan-based chemotherapy. Cancer 2006 Mar 106 (5): 1007-16. Massacesi Cristian, Terrazzino Salvatore, Marcucci Fabiana, Rocchi Marco B, Lippe Paolo, Bisonni Renato, Lombardo Marco, Pilone Alberta, Mattioli Rodolfo, Leon Alber |
| UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma. Cancer 2008 May 112 (9): 1932-40. Liu Chun-Yu, Chen Po-Min, Chiou Tzeon-Jye, Liu Jin-Hwang, Lin Jen-Kou, Lin Tzu-Chen, Chen Wei-Shone, Jiang Jeng-Kae, Wang Huann-Sheng, Wang Wei-S |
| Clinical significance of UDP-glucuronosyltransferase 1A1*6 for toxicities of combination chemotherapy with irinotecan and cisplatin in gynecologic cancers: a prospective multi-institutional study. Oncology 2009 76 (5): 315-21. Takano Masashi, Kato Masafumi, Yoshikawa Tomoyuki, Sasaki Naoki, Hirata Junko, Furuya Kenichi, Takahashi Michiko, Yokota Harushige, Kino Nao, Horie Koji, Goto Tomoko, Fujiwara Keiichi, Ishii Kenji, Kikuchi Yoshihiro, Kita Tsuneka |
| Associations of various gene polymorphisms with toxicity in colorectal cancer patients receiving oral uracil and tegafur plus leucovorin: a prospective study. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011 Feb 22 (2): 355-61. Tsunoda A, Nakao K, Watanabe M, Matsui N, Ooyama A, Kusano |
| Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. British journal of cancer 2010 Apr 102 (9): 1371-7. Xu C-F, Reck B H, Xue Z, Huang L, Baker K L, Chen M, Chen E P, Ellens H E, Mooser V E, Cardon L R, Spraggs C F, Pandite |
| Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer. International journal of cancer. Journal international du cancer 2010 Dec 127 (12): 2815-21. Lacko Martin, Roelofs Hennie M J, Te Morsche Rene H M, Voogd Adri C, Ophuis Michel B Oude, Peters Wilbert H M, Manni Johannes |
| High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk. International journal of oncology 2012 Jun 40 (6): 1789-96. Dura Polat, Salomon Jody, Te Morsche Rene H M, Roelofs Hennie M J, Kristinsson Jon O, Wobbes Theo, Witteman Ben J M, Tan Adriaan C I T L, Drenth Joost P H, Peters Wilbert H |
| Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma. Anti-cancer drugs 2012 Dec . Tsuchiya N, Narita S, Inoue T, Hasunuma N, Numakura K, Horikawa Y, Satoh S, Notoya T, Fujishima N, Hatakeyama S, Ohyama C, Habuchi T |
| UGT1A1 genotype-specific phase I and pharmacokinetic study for combination chemotherapy with irinotecan and cisplatin: a Saitama Tumor Board study. European journal of gynaecological oncology 2013 34 (2): 120-3. Takano M, Goto T, Hirata J, Furuya K, Horie K, Takahashi M, Yokota H, Kino N, Kudoh K, Kikuchi |
| Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction. Cancer prevention research (Philadelphia, Pa.) 2015 Dec . Lacombe Louis, Fradet Vincent, Levesque Eric, Pouliot Frederic, Larue Hélène, Bergeron Alain, Hovington Hélène, Caron André, Nguile-Makao Molière, Harvey Mario, Fradet Yves, Guillemette Chant |
| Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer. Cell biology and toxicology 2016 Jun . Bao Lianmin, Zhang Yong, Wang Jian, Wang Haiyun, Dong Nian, Su Xiaoqiong, Xu Menglin, Wang Xiangdo |
| Association between UGT1A1*28*28 genotype and lung cancer in the Japanese population. International journal of clinical oncology 2016 Nov . Nishikawa Yoshitaka, Kanai Masashi, Narahara Maiko, Tamon Akiko, Brown J B, Taneishi Kei, Nakatsui Masahiko, Okamoto Kazuya, Uneno Yu, Yamaguchi Daisuke, Tomono Teruko, Mori Yukiko, Matsumoto Shigemi, Okuno Yasushi, Muto Mana |
| Association between UGT1A1 Polymorphism and Risk of Laryngeal Squamous Cell Carcinoma. International journal of environmental research and public health 2016 13 (1): . Huangfu Hui, Pan Hong, Wang Binquan, Wen Shuxin, Han Rui, Li |
| UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population. Liver international : official journal of the International Association for the Study of the Liver 2017 09 37 (9): 1345-1353. De Mattia Elena, Cecchin Erika, Polesel Jerry, Lupo Francesco, Tiribelli Claudio, Crovatto Marina, Buonadonna Angela, Toffoli Giusep |
| UGT1A1 polymorphism as a prognostic indicator of stage I ovarian clear cell carcinoma patients treated with irinotecan. Japanese journal of clinical oncology 2017 Feb 47 (2): 170-174. Yoshihama Tomoko, Hirasawa Akira, Nomura Hiroyuki, Akahane Tomoko, Nanki Yoshiko, Yamagami Wataru, Kataoka Fumio, Tominaga Eiichiro, Susumu Nobuyuki, Mushiroda Taisei, Aoki Daisu |
| Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan-related toxicities in patients with lung cancer. Thoracic cancer 2017 Oct . Fukuda Minoru, Okumura Manabu, Iwakiri Tomomi, Arimori Kazuhiko, Honda Takuya, Kobayashi Kazuma, Senju Hiroaki, Takemoto Shinnosuke, Ikeda Takaya, Yamaguchi Hiroyuki, Nakatomi Katsumi, Matsuo Nobuko, Mukae Hiroshi, Ashizawa Kazu |
| Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma. Medical oncology (Northwood, London, England) 2018 Mar 35 (4): 51. Igarashi Ryoma, Inoue Takamitsu, Fujiyama Nobuhiro, Tsuchiya Norihiko, Numakura Kazuyuki, Kagaya Hideaki, Saito Mitsuru, Narita Shintaro, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
| Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population. Medical science monitor : international medical journal of experimental and clinical research 2019 Apr 25 2959-2965. Zhang Shudong, Wang Binshuai, Zhang Fan, Ye Jianfei, Ge Liyuan, Ma Lul |
| UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study. BMC cancer 2020 Aug 20 (1): 729. Matsuoka Hideki, Murakami Ryusuke, Abiko Kaoru, Yamaguchi Ken, Horie Akihito, Hamanishi Junzo, Baba Tsukasa, Mandai Masa |
| [Correlation between nUGT1A1 gene polymorphisms and adverse events of irinotecan plus S-1 for patients with recurrent or metastatic esophageal squamous cell carcinoma: a prospective, open-label, randomized controlled trial (ESWN 01)]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2021 11 43 (11): 1177-1182. Wang X, Liu Y, Huang J X, Lu P, Ba Y, Wu L, Bai Y X, Zhang S, Feng J F, Cheng Y, Li J, Wen L, Yuan X L, Ma C W, Hu C H, Fan Q X, Xu B H, Huang |
| UGT1A1 Gene Polymorphism Contributes as a Risk Factor for Lung Cancer: A Pilot Study with Patients from the Amazon. Genes 2022 3 13 (3): . Pereira Esdras E B, Leitão Luciana P C, Andrade Roberta B, Modesto Antônio A C, Fernandes Bruno M, Burbano Rommel M R, Assumpção Paulo P, Fernandes Marianne R, Guerreiro João F, Santos Sidney E B Dos, Santos Ney P C D |
| Delayed Diagnosis of Clostridium difficile Colitis in a 48-Year-Old Woman with a Homozygous Mutation of the UGT1A1 Gene While on Chemotherapy for Colorectal Carcinoma. The American journal of case reports 2022 2 23 e934361. Caramoci Adela, Grigorescu Alexandru, Pop Mirela, Ionescu Anca Mire |
| Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism. Clinical genitourinary cancer 2024 8 102180. Sajedeh Mobaraki, Peter Henrik Nissen, Frede Donskov, Agnieszka Wozniak, Yannick Van Herck, Lina Coosemans, Tine van Nieuwenhuyse, Diether Lambrechts, Oliver Bechter, Marcella Baldewijns, Eduard Roussel, Annouschka Laenen, Benoit Beuselin |
| TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes. Annals of oncology : official journal of the European Society for Medical Oncology 2024 1 . Y Loriot, D P Petrylak, A Rezazadeh Kalebasty, A Fléchon, R K Jain, S Gupta, M Bupathi, P Beuzeboc, P Palmbos, A V Balar, C E Kyriakopoulos, D Pouessel, C N Sternberg, J Tonelli, M Sierecki, H Zhou, P Grivas, P Barthélémy, S T Taga |
- Page last reviewed:Feb 1, 2024
- Content source: